Trends in cost of treatment of lung cancer patients in 2014–2019 in Finland – a descriptive register study

References

• Luengo-Fernandez R, Leal J, Gray A, et al. Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol. 2013;14(12):1165–1174. doi: 10.1016/S1470-2045(13)70442-X
   PubMed Web of Science ®Google Scholar
• Laudicella M, Walsh B, Burns E, et al. Cost of care for cancer patients in England: evidence from population-based patient-level data. Br J Cancer. 2016;114(11):1286–1292. doi: 10.1038/bjc.2016.77
   PubMed Web of Science ®Google Scholar
• Torkki P, Leskelä RL, Linna M, et al. Cancer costs and outcomes in the Finnish population 2004–2014. Acta Oncol. 2018;57(2):297–303. doi: 10.1080/0284186X.2017.1343495
   PubMed Web of Science ®Google Scholar
• Yabroff KR, Mariotto AB, Feuer E, et al. Projections of the costs associated with colorectal cancer care in the United States, 2000–2020. Health Econ. 2008;17(8):947–959. doi: 10.1002/hec.1307
   PubMed Web of Science ®Google Scholar
• Bhalla N, Brooker R, Brada M. Combining immunotherapy and radiotherapy in lung cancer. J Thorac Dis. 2018;10(Suppl 13):S1447–S1460. doi: 10.21037/jtd.2018.05.107
   PubMedGoogle Scholar
• Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389(10066):299–311. doi: 10.1016/S0140-6736(16)30958-8
   PubMed Web of Science ®Google Scholar
• Leidl R, Wacker M, Schwarzkopf L. Better understanding of the health care costs of lung cancer and the implications. Expert Rev Respir Med. 2016;10(4):373–375. doi: 10.1586/17476348.2016.1149064
   PubMed Web of Science ®Google Scholar
• Koivunen J, Knuuttila A, Mali P. Levinneen keuhkosyövän nykyaikainen lääkehoito – mitä totunnaisten solunsalpaajien lisäksi? Duodecim. 2016;132:555–560.
   PubMedGoogle Scholar
• Palmer S, Kuhlmann GL, Pothier K. IO nation: the rise of immuno-oncology, current pharmacogenomics and personalized medicine (formerly current pharmacogenomics). CPPM. 2015;12(3):176–181. doi: 10.2174/1875692113666150115222451
   Google Scholar
• DiBonaventura MD, Shah-Manek B, Higginbottom K, et al. Adherence to recommended clinical guidelines in extensive disease small-cell lung cancer across the US, Europe, and Japan. Ther Clin Risk Manag. 2019;15:355–366. doi: 10.2147/TCRM.S183216
   PubMed Web of Science ®Google Scholar
• Lindqvist J, Jekunen A, Sihvo E, et al. Effect of adherence to treatment guidelines on overall survival in elderly non-small-cell lung cancer patients. Lung Cancer. 2022;171:9–17. doi: 10.1016/j.lungcan.2022.07.006
   PubMed Web of Science ®Google Scholar
• Nicolson M. ES05. 01 lung cancer survival: progress and challenges. Thor Oncol. 2019;14(10):S24. doi: 10.1016/j.jtho.2019.08.087
   Web of Science ®Google Scholar
• Voda A, Bostan I. Public health care financing and the costs of cancer care: a cross-national analysis. Cancers. 2018;10(4):117. doi: 10.3390/cancers10040117
   PubMed Web of Science ®Google Scholar
• Sullivan R, Peppercorn J, Sikora K, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol. 2011;12(10):933–980. doi: 10.1016/S1470-2045(11)70141-3
   PubMed Web of Science ®Google Scholar
• McGuire A, Martin M, Lenz C, et al. Treatment cost of non-small cell lung cancer in three european countries: comparisons across France, Germany, and England using administrative databases. J Med Econ. 2015;18(7):525–532. doi: 10.3111/13696998.2015.1032974
   PubMed Web of Science ®Google Scholar
• Fox KM, Brooks J, Kim J. Metastatic non-small cell lung cancer: costs associated with disease progression. Am J Manag Care. 2008;14(9):565–571.
   PubMed Web of Science ®Google Scholar
• Skinner KE, Fernandes AW, Walker MS, et al. Healthcare costs in patients with advanced non-small cell lung cancer and disease progression during targeted therapy: a real-world observational study. J Med Econ. 2018;21(2):192–200. doi: 10.1080/13696998.2017.1389744
   PubMed Web of Science ®Google Scholar
• Kapiainen S, Väisänen A, Haula T. Terveyden- ja sosiaalihuollon yksikkökustannukset suomessa vuonna 2011. Finnish Institute for Health and Welfare. 2014.
   Google Scholar
• Hoitojaksotietokanta [Data file], Finnish Institute for Health and Welfare; 2020.
   Google Scholar
• Leskelä R-L, Peltonen E, Haavisto I, et al. Trends in treatment of non-small cell lung cancer in Finland 2014–2019. Acta Oncol. 2022;61(5):641–648. doi: 10.1080/0284186X.2022.2042474
   PubMed Web of Science ®Google Scholar
• Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075. doi: 10.1016/S0140-6736(17)33326-3
   PubMed Web of Science ®Google Scholar